Evidence map›Paper›PMID 35347363›Full record

ArticleEuropean radiology2022

Combined quantitative T2 mapping and [

Miao Zhang, Hui Huang, Wei Liu, Lihong Tang, Qikang Li, Jia Wang, Xinyun Huang, Xiaozhu Lin, Hongping Meng, Jin Wang and 3 more

Abstract read
In one paragraph

Article in European radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. [European radiology · 2024
    Article
  6. Simultaneous high-resolution whole-brain MR spectroscopy and [European journal of nuclear medicine and molecular imaging · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Miao Zhang *Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China.
Hui Huang *School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
Wei LiuDepartment of Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China.
Lihong TangSchool of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
Qikang LiSchool of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
Jia WangSchool of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
Xinyun HuangDepartment of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China.
Xiaozhu LinDepartment of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China.
Hongping MengDepartment of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China.
Jin WangDepartment of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China.
Shikun ZhanDepartment of Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China.
Biao LiDepartment of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China. lb10363@rjh.com.cn.
Jie LuoSchool of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China. jieluo@sjtu.edu.cn.ORCID http://orcid.org/0000-0002-0543-4778

Funding

Ministry of Science and Technology of the People's Republic of China No. 2017YFC0109002Shanghai Municipal Key Clinical Specialty No. shslczdzk03403Shanghai Science and Technology Commission project No.17411964800Three-year planning of the Shanghai Shen-Kang Promoting Hospital's Clinical Skills and Innovative Ability Project No. 16CR3110B
6 · The paper itself

Abstract

objectivesTo investigate whether quantitative T2 mapping is complementary to [

methodsWe acquired routine structural MRI, T2-weighted FLAIR, whole brain T2 mapping, and [

resultsRoutine structural MRI and T2w-FLAIR lateralized 47.8% (22/46) of MTLE patients, and FDG PET lateralized 84.8% (39/46). T2 mapping combined with [

conclusionsThe combination of quantitative T2 mapping and [ KEY POINTS: • Quantitative T2 mapping and

Indexed as

Epilepsy, Temporal LobeFluorodeoxyglucose F18HumansMagnetic Resonance ImagingPositron-Emission TomographyTemporal LobeTomography, X-Ray ComputedFluorodeoxyglucose F18Hippocampal sclerosisLateralizationPET/MRT2 mappingTemporal lobe epilepsy

Identifiers

PMID35347363
PMCPMC9381472

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.